A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

NCT06328400 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: Deuremidevir Hydrobromide for Suspension
DRUG: Deuremidevir Hydrobromide for Suspension Placebo

Sponsor

Vigonvita Life Sciences